Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 14/2023

Inhalt (70 Artikel)

Open Access Research

Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancer

Fabinshy Thangarajah, Jana Busshoff, Janina Salamon, Marie-Sandrine Pruss, Caroline Lenz, Bernd Morgenstern, Martin Hellmich, Hans Anton Schlößer, Maximilian Lenz, Christian Domröse, Michael R. Mallmann, Peter Mallmann, Jonathan Weiß, Fabian Franzen, Sabine Merkelbach-Bruse, Elke Binot, Marie-Lisa Eich, Reinhardt Büttner, Anne Maria Schultheis, Christina Alidousty

Research

Identifying immune infiltration by deep learning to assess the prognosis of patients with hepatocellular carcinoma

Weili Jia, Wen Shi, Qianyun Yao, Zhenzhen Mao, Chao Chen, AQiang Fan, Yanfang Wang, Zihao Zhao, Jipeng Li, Wenjie Song

Research

The study of an anoikis-related signature to predict glioma prognosis and immune infiltration

Dongdong Zhang, Yu Wang, Huandi Zhou, Xuetao Han, Liubing Hou, Zhongqiang Lv, Xiaoying Xue

Research

Dynamic changes in three biomarkers predict early-stage hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy

Qianyu Zhu, Jialing Zhou, Hongyi Li, Hui Wang, Jiangbo Ren, Shujie Sun, Miaoran Yang, Shanshan Wu, Ming Cao, Kaixiang Wang, Hong You, Hong Ma

Research

Outcome benefits of bevacizumab biosimilar (SIBP04) combined with carboplatin and paclitaxel in advanced non-squamous non-small-cell lung cancer patients with EGFR mutation: subgroup analysis of a prospective, randomized phase III clinical trial

Aidong Qu, Shiying Zhang, Hongxia Zou, Sixiu Li, Dandan Chen, Yaowen Zhang, Songsong Li, Huijun Zhang, Ji Yang, Yunkai Yang, Yubao Huang, Xiuling Li, Yuntao Zhang

Open Access Research

Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG)

Frederik A. Stuebs, Matthias W. Beckmann, Tanja Fehm, Christian Dannecker, Markus Follmann, Thomas Langer, Simone Wesselmann

Research

Multi-omics analysis of expression profile and prognostic values of connexin family in LUAD

Peng Jiang, Xingfa Huo, Bowen Dong, Na Zhou, Xiaochun Zhang

Research

The elusive Luminal B breast cancer and the mysterious chemokines

Rogério Agenor de Araújo, Felipe Andrés Cordero da Luz, Eduarda da Costa Marinho, Camila Piqui Nascimento, Thais Rezende Mendes, Etelvina Rocha Tolentino Mosca, Lara de Andrade Marques, Patrícia Ferreira Ribeiro Delfino, Rafael Mathias Antonioli, Ana Cristina Araújo Lemos da Silva, Maria Luiza Gonçalves dos Reis Monteiro, Morun Bernardino Neto, Marcelo José Barbosa Silva

Research

Hospital volume and prognosis of patients with metastatic pancreatic cancer: A study using the Osaka Cancer Registry

Yasuharu Kawamoto, Kenji Ikezawa, Takahiro Tabuchi, Toshitaka Morishima, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Sena Higashi, Makiko Urabe, Yugo Kai, Ryoji Takada, Takuo Yamai, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Isao Miyashiro, Kazuyoshi Ohkawa

Open Access Research

A novel disulfidptosis-related immune checkpoint genes signature: forecasting the prognosis of hepatocellular carcinoma

Yuxin Chen, Wanying Xue, Yuting Zhang, Yu Gao, Yuanyuan Wang

Open Access Research

Implementation of a clinical long-term follow-up database for adult childhood cancer survivors in Germany: a feasibility study at two specialised late effects clinics

Madelaine Sleimann, Magdalena Balcerek, Chirine Cytera, Franziska Richter, Anja Borgmann-Staudt, Bernhard Wörmann, Lea Louisa Kronziel, Gabriele Calaminus, Ann-Kristin Kock-Schoppenhauer, Desiree Grabow, Katja Baust, Anke Neumann, Thorsten Langer, Judith Gebauer

Open Access Research

Establishment of a prognostic model based on m6A regulatory factors and stemness of hepatocellular carcinoma using RNA-seq data and scRNA-seq data

Yan Liang, Sen Chen, Jinghe Xie, Guanrong Yan, Tingting Guo, Tianyang Li, Shoupei Liu, Weiping Zeng, Shuai Zhang, Keqiang Ma, Honglin Chen, Yimeng Ou, Bailin Wang, Weili Gu, Yuyou Duan

Open Access Research

A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials

Anna Fleischer, Larissa Zapf, Johannes Allgaier, Karin Jordan, Götz Gelbrich, Rüdiger Pryss, Johannes Schobel, Max Bittrich, Hermann Einsele, Martin Kortüm, Imad Maatouk, Niels Weinhold, Leo Rasche

Open Access Research

Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting

M. Zurloh, M. Goetz, T. Herold, J. Treckmann, P. Markus, B. Schumacher, D. Albers, A. Rink, V. Rosery, G. Zaun, K. Kostbade, M. Pogorzelski, S. Ting, H. Schmidt, R. Stiens, M. Wiesweg, M. Schuler, Stefan Kasper, I. Virchow

Open Access Research

The role of surgery in the treatment of neuroblastoma metastases at rare sites

Simon Scherer, Benjamin F. B. Mayer, Markus Dietzel, Michael Esser, Steven W. Warmann, Peter Lang, Martin U. Schuhmann, Andreas Schmidt, Jörg Fuchs

Research

Claudin18.2 expression in pulmonary mucinous adenocarcinoma

Yuming Wang, Yike Gao, Zhiwen Zhang, Zixin Zhang, Anqi Wang, Kun Zhao, Miao Zhang, Sumei Zhang, Mei Li, Jian Sun, Dan Guo, Zhiyong Liang

Open Access Research

Screening biomarkers for predicting the efficacy of immunotherapy in patients with PD-L1 overexpression

Xiaodan Zhu, Bo Yu, Yanli Shen, Yan Zhao, Xiyujing Fu, Yunji Zhu, Guomin Gu, Chunling Liu

Research

Diagnosis and prognosis of pancreatic cancer with immunoglobulin heavy constant delta blood marker

Qiyang Chen, Qingsong Guo, Dongzhi Wang, Shajun Zhu, Di Wu, Zhiwei Wang, Yuhua Lu

Research

A radiomics-clinical combined nomogram-based on non-enhanced CT for discriminating the risk stratification in GISTs

Peizhe Wang, Jingrui Yan, Hui Qiu, Jingying Huang, Zhe Yang, Qiang Shi, Chengxin Yan

Research

Radiomics features from whole thyroid gland tissue for prediction of cervical lymph node metastasis in the patients with papillary thyroid carcinoma

Siyuan Lu, Yongzhen Ren, Chao Lu, Xiaoqin Qian, Yingzhao Liu, Jiulou Zhang, Xiuhong Shan, Eryi Sun

Open Access Research

Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization

Heidrun Hirner-Eppeneder, Elif Öcal, Matthias Stechele, Osman Öcal, Sijing Gu, Melanie A. Kimm, Moritz Wildgruber, Lukas Salvermoser, Philipp Kazmierczak, Stefanie Corradini, Martina Rudelius, Guido Piontek, Maciej Pech, S. Nahum Goldberg, Jens Ricke, Marianna Alunni-Fabbroni

Open Access Research

In-vitro model to mimic T cell subset change in human PDAC organoid co-culture

M. Knoblauch, T. Ma, I. Beirith, D. Koch, F. Hofmann, K. Heinrich, U. Aghamaliev, S. Sirtl, C. B. Westphalen, H. Nieß, M. Reichert, M. K. Angele, I. Regel, A. V. Bazhin, J. Werner, M. Ilmer, Bernhard W. Renz

Open Access Research

Perivascular epithelioid cell tumors (PEComas) of the bone and soft tissue: a Japanese Musculoskeletal Oncology Group (JMOG) multi-institutional study

Yuya Izubuchi, Shunsuke Hamada, Yoshikazu Tanzawa, Ikuo Fujita, Jungo Imanishi, Hirotaka Koyanagi, Akiyoshi Shimatani, Tadashi Komatsubara, Takaaki Tanaka, Mana Fukushima, Yoshiaki Imamura, Takafumi Ueda, Hirotaka Kawano, Akihiko Matsumine

Open Access Research

A nomogram incorporating Ki67 to predict survival of acral melanoma

Yu Du, Caili Li, Lili Mao, Xiaoting Wei, Xue Bai, Zhihong Chi, Chuanliang Cui, Xinan Sheng, Bin Lian, Bixia Tang, Xuan Wang, Xieqiao Yan, Siming Li, Li Zhou, Jun Guo, Lu Si

Research

Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker

Zhujiang Dai, Xiang Peng, Xuewei Cui, Yuegui Guo, Jie Zhang, Xia Shen, Chen-Ying Liu, Yun Liu

Research

Identification of lactate-related subgroups and prognostic model in triple-negative breast cancer

Shan-Shan Huang, Lin-Yu Wu, Yu Qiu, Yi Xie, Hao Wu, Ying-Qing Li, Xin-Hua Xie

Research

Cucurbitacin C as an effective anti-cancer agent: unveiling its potential role against cholangiocarcinoma and mechanistic insights

Wangyang Chen, Qiang Liu, Zhicheng Huang, Chenyu Le, Yu Wang, Jianfeng Yang

Research

Efficacy of immune checkpoint inhibitors in younger patients with non-small cell lung cancer

Shinkichi Takamori, Mototsugu Shimokawa, Takefumi Komiya

Research

Identification of cytokine-predominant immunosuppressive class and prognostic risk signatures in glioma

Ziyue Tian, Zhongyi Yang, Meng Jin, Ran Ding, Yuhan Wang, Yuying Chai, Jinpu Wu, Miao Yang, Weimin Zhao

Research

Salvage prostate bed plus elective pelvic node radiation without androgen deprivation therapy

Gregory P. Swanson, Kendall Hammonds, Sameer Jhavar

Research

A potential novel biomarker: comprehensive analysis of prognostic value and immune implication of CES3 in colonic adenocarcinoma

Lulu He, Chenyi Zhao, Jingjing Xu, Wenjing Li, Yujie Lu, Yang Gong, Dingyi Gu, Xiaoyan Wang, Feng Guo

Research

Is there any prognostic significance in pleural involvement and/or effusion in patients with ALK-positive NSCLC?

Gürkan Güner, Burak Yasin Aktaş, Fatma Buğdaycı Başal, Ahmet Demirkazık, Pınar Gürsoy, Umut Demirci, Mustafa Erman, Perran Fulden Yumuk, Filiz Çay Şenler, Burcu Çakar, İrfan Çiçin, Akın Öztürk, Hasan Şenol Coşkun, Erdem Çubukçu, Abdurrahman Işıkdoğan, Ömer Fatih Ölmez, Ali Murat Tatlı, Mustafa Karaağaç, Teoman Şakalar, Yeşim Eralp, Taner Korkmaz, Saadettin Kılıçkap

Research

Cancer outpatients during the COVID-19 pandemic: what Oncoral has to teach us about medical drug use and the perception of telemedicine

V. Larbre, N. Romain-Scelle, P. Reymond, Y. Ladjouzi, C. Herledan, A. G. Caffin, A. Baudouin, M. Maire, D. Maucort-Boulch, F. Ranchon, C. Rioufol

Research

The additional radiotherapy to adjuvant chemotherapy improves the prognosis of stage III-N2 with highest mediastinal lymph node metastasis in non-small cell lung cancer

Jianbo Guo, Lei Zhang, Liping Zhang, Junqi Wu, Long Xu, Haoran E, Chongwu Li, Hongyu Wu, Deping Zhao, Yumin Hu, Jie Zhang, Xuefei Hu

Open Access Research

A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands

Marieke Pape, Pauline A. J. Vissers, Ken Kato, Nadia Haj Mohammad, Bastiaan Klarenbeek, Hanneke W. M. van Laarhoven, Tomohiro Matsuda, Rob H. A. Verhoeven

Open Access Research

Programmed death-ligand 1 (PD-L1) expression in primary gastric adenocarcinoma and matched metastases

Drolaiz H. W. Liu, Heike I. Grabsch, Beat Gloor, Rupert Langer, Bastian Dislich

Research

Radiomics‑Clinical model based on 99mTc-MDP SPECT/CT for distinguishing between bone metastasis and benign bone disease in tumor patients

Huili Wang, Jianfeng Qiu, Jindong Xie, Weizhao Lu, Yuteng Pan, Junchi Ma, Mingsheng Jia

Open Access Research

Early clinical trial unit tumor board: a real-world experience in a national cancer network

L. Weiss, K. Dorman, M. Boukovala, F. Schwinghammer, P. Jordan, T. Fey, K. Hasselmann, M. Subklewe, V. Bücklein, R. Bargou, M. Goebeler, C. Sayehli, S. Spoerl, F. Lüke, D. Heudobler, R. Claus, I. von Luettichau, S. Lorenzen, S. Lange, C. B. Westphalen, M. von Bergwelt-Baildon, V. Heinemann, C. Gießen-Jung

Research

Conditional survival of elderly primary central nervous system lymphoma

Hui Qian, Zhihao Yang, Linqiang Cai, Huawei Chen

Open Access Research

Individual surveillance by competing risk model for patients with hepatocellular carcinoma occurrence in all-cause cirrhosis

Qi Wang, Dandan Guo, Wenfeng Gao, Chunwang Yuan, Jianjun Li, Yinghua Zhang, Ning He, Peng Zhao, Jiasheng Zheng, Yonghong Zhang

Open Access Review

The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer

Sarah Maloney, Stephen J. Clarke, Sumit Sahni, Amanda Hudson, Emily Colvin, Anubhav Mittal, Jaswinder Samra, Nick Pavlakis

Review

Advances in bio-immunotherapy for castration-resistant prostate cancer

Canling Lin, Yonghui Chen, Liji Shi, Huarong Lin, Hongmei Xia, Weihua Yin

Review

Akkermansia muciniphila: a potential booster to improve the effectiveness of cancer immunotherapy

Shiying Fan, Zhengting Jiang, Zhilin Zhang, Juan Xing, Daorong Wang, Dong Tang

Correspondence

Letter to the Editor: ChatGPT's contribution to cancer study

Niloofar Faraji, Shahab Aali, Mahsa Motiei, Sahand Sadat Mansouri

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.